BetaShares Global Healthcare ETF - Currency Hedged (ASX: DRUG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
BetaShares Global Healthcare ETF - Currency Hedged Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
BetaShares Global Healthcare ETF - Currency Hedged (ASX: DRUG)
Latest News
Healthcare Shares
How can ASX investors buy the US stock the WHOLE world is talking about?
ETFs
'Beyond our expectations': How to invest in obesity drugs like Ozempic with ASX ETFs
ETFs
3 defensive ASX ETFs to buy if a recession comes
ETFs
Expert names 2 excellent ASX ETFs to buy
ETFs
Expert names the ETFs to buy this month
ETFs
Betashares names 6 'defensive' ASX ETFs to consider for a possible recession
ETFs
A defensive ASX ETF for a recessionary environment: experts
Share Market News
ETF provider VanEck to launch 4 new ASX ETFs
DRUG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Edward Sippel | Non-Executive Director | Mar 2021 |
No Profile Reported in Annual Report.
|
| Mr Alex Vynokur | Executive Director | Sep 2009 |
Mr Vynokur is responsible for leading the strategy and overall management of the business. Alex was involved in the establishment and development of several Australian financial services businesses including Pengana Capital and Centric Wealth. Alex is a director and principal of Apex Capital Partners. He is also a director of Toranotec Ltd. Alex previously worked at Turnbull Pillemer Capital, where he focussed on identifying and managing investments across the financial services industry. Prior to commencing his career in financial services, Alex was a lawyer at Baker & McKenzie, specialising in mergers and acquisitions and financial services.
|
| Mr Jason Gellert | Executive Director | Mar 2021 |
Mr Gellert worked in the private equity advisory group at Morgan Stanley in New York and their mergers and acquisitions group in Sydney. He also worked in the investment team at Investec Wentworth Private Equity. Jason's experience spans mergers and acquisitions, capital markets and general corporate advice, as well as funds management.
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| No Top 20 Shareholder Information | 0 | 0.00% |
